<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:obo="http://purl.obolibrary.org/obo/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>BMC Molecular Biology                                                                                                                       BioMed Central <br />  <br />  <br />  <br /> Research article                                                                                                                          Open Access <br /> Viable nonsense mutants essential gene SUP45 Saccharomyces cerevisiae <br /> Svetlana E Moskalenko1,2, Svetlana V Chabelskaya1,2, Sergei G Inge- <br /> Vechtomov2, Michel Philippe1 Galina Zhouravleva*1,2 <br />  <br /> Address: 1Universit&#195;&#169; Rennes 1, CNRS UMR 6061, IFR 97, 2 av. Pr. L&#195;&#169;on Bernard 35043 Rennes Cedex, France 2Department Genetics, St <br /> Petersburg State University, Universitetskaya emb. 7/1, 199034, St Petersburg, Russia <br /> Email: Svetlana E Moskalenko - smoskalenko@hotmail.com; Svetlana V Chabelskaya - sveta@btc.bio.pu.ru; Sergei G Inge- <br /> Vechtomov - inge@mailru.com; Michel Philippe - michel.philippe@univ-rennes1.fr; Galina Zhouravleva* - galina@btc.bio.pu.ru <br /> * Corresponding author <br />  <br />  <br />  <br />  <br /> Published: 10 February 2003                                                   Received: 29 November 2002 <br />                                                                               Accepted: 10 February 2003 <br /> BMC Molecular Biology 2003, 4:2   doi:10.1186/1471-2199-4-2 article available  http://www.biomedcentral.com/1471-2199/4/2 <br /> &#194;&#169; 2003 Moskalenko et al; licensee BioMed Central  Open Access article: verbatim copying redistribution article permitted media purpose, provided notice preserved article&apos;s original URL. <br />  <br />  <br />  <br />  <br />                  Abstract <br />                  Background: Termination protein synthesis eukaryotes involves polypeptide <br />                  release factors (eRFs) &#226;&#8364;&#8220; eRF1 eRF3. highly conserved translation termination factor eRF1 <br />                  Saccharomyces cerevisiae encoded essential gene SUP45. <br />                  Results: isolated sup45-n (n nonsense) mutations cause nonsense <br />                  substitutions following <span id='am-25' about='obo:IMR_0001695' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001'><span id='am-26' property="oboInOwl:hasDbXref" content="MeSH:D000596" datatype="xsd:string"></span><span id='am-27' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-28' property="oboInOwl:hasDbXref" content="CHEBI:33709" datatype="xsd:string"></span><span id='am-29' property="obo:IAO_0000115" content="Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins." datatype="xsd:string"></span><span id='am-30' property="oboInOwl:id" content="IMR:0001695" datatype="xsd:string"></span><span id='am-31' property="rdfs:label" content="amino acid" datatype="xsd:string"></span>amino acid</span> positions eRF1: Y53 &#226;&#8224;&#8217; UAA, E266 &#226;&#8224;&#8217; UAA, L283 &#226;&#8224;&#8217; <br />                  UAA, L317 &#226;&#8224;&#8217; UGA, E385 &#226;&#8224;&#8217; UAA. length eRF1 protein present mutants, <br />                  decreased amounts. mutations situated weak termination context.                  sup45-n mutations viable different genetic backgrounds, viability increases <br />                  growth absence wild-type allele. sup45-n mutations result temperature <br />                  sensitivity (37&#194;&#176;C). sup45-n mutations lead decreased spore viability spores <br />                  bearing sup45-n mutations characterized limited budding germination leading                  formation microcolonies 4&#226;&#8364;&#8220;20 cells. <br />                  Conclusions: Nonsense mutations essential gene SUP45 isolated absence                  tRNA nonsense suppressors. <br />  <br />  <br />  <br />  <br /> Background                                                                     Release factor eRF1 recognizes stop codons [5], Termination protein synthesis occurs ribos-                        contrast prokaryotes RF1 catalyses translation <br /> ome elongation machinery encounters frame termi-                         termination UAG UAA codons, RF2 UGA <br /> nation (stop) codon, UAG, UGA UAA,                            UAA codons [6]. proteins encoded mRNA. stop codon located site ribos-                      essential genes: prfA  RF1), prfB  RF2) bacteria <br /> ome recognized release factor (RF1/RF2 prokary-                     [7-9] SUP45  eRF1) S. cerevisiae [10,11]. <br /> otes eRF1 eukaryotes), triggers release                    sequences prokaryotic eukaryotic <br /> nascent <span id='am-1' about='obo:IMR_0001700' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001'><span id='am-2' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-3' property="oboInOwl:id" content="IMR:0001700" datatype="xsd:string"></span><span id='am-4' property="obo:IAO_0000115" content="The polypeptide that is not a gene product." datatype="xsd:string"></span><span id='am-5' property="rdfs:label" content="peptide" datatype="xsd:string"></span>peptide</span> ribosome. Termination effi-                           release factors differ significantly  [12] review], ciency enhanced GTPase release factor, RF3                        &quot;tRNA-mimicry&quot; model generalizing mechanisms prokaryotes eRF3 eukaryotes [reviewed [1-4]].                        prokaryotic eukaryotic translation termination,                                                                                proposed [13]. Peptide determinants RF1 RF2 <br />  <br />  <br />                                                                                                                                           Page 1 13 <br />                                                                                                                     (page number citation purposes) <br />  BMC Molecular Biology 2003, 4:2                                                      http://www.biomedcentral.com/1471-2199/4/2 <br />  <br />  <br />  <br /> involved specificity stop codon recognition            tants obtained. sup45 mutant alleles identified: cases tripeptide (PAT RF1              wild-type SUP45 allele parent strain 1B- SPF RF2) located homologous region              D1606 cloned using PCR. DNA sequence proteins [14].                                                   cloned alleles determined. <br />  <br /> Recently crystal structures human eRF1 bacte-              sequencing parent strain 1B-D1606 revealed 6 <br /> rial RF2 determined different               <span id='am-17' about='obo:IMR_0001349' typeof='owl:Thing obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001698'><span id='am-18' property="oboInOwl:id" content="IMR:0001349" datatype="xsd:string"></span><span id='am-19' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-20' property="rdfs:label" content="nucleotide" datatype="xsd:string"></span><span id='am-21' property="obo:IAO_0000115" content="A nucleotide consists of a nitrogen-containing base, a five-carbon sugar, and one or more phosphate groups. Nucleotides can carry chemical energy (e.g. ATP), form coenzymes (e.g. CoA), be used as specific signaling molecules (e.g. cAMP) in the cell. Nucleotides are the subunits of the nucleic acids. " datatype="xsd:string"></span><span id='am-22' property="oboInOwl:hasDbXref" content="CHEBI:25608" datatype="xsd:string"></span><span id='am-23' property="oboInOwl:hasExactSynonym" content="nucleoside phosphate" datatype="xsd:string"></span><span id='am-24' property="rdfs:label" content="nucleoside phosphate" datatype="xsd:string"></span>nucleotide</span> substitutions compared published <br /> [15,17].  associated ribosome RF2,                sequence [10]: A69G, G519T, T687C, T702A, G927A, <br /> conformation modified mimics tRNA molecule                   T1008C.  T702, [16,18]. eRF1 RF2 comparable                   described earlier [10] mutant alleles obviously <br /> structures compatible tRNA mim-                different origin regarding wild-type strain. icry model proposed previously [13]. eRF1 com-              nucleotide substitutions localized codon <br /> posed domains. Domain 3 corresponds C-                position change amino acid residues. terminal eRF1 necessary interaction           reason differences origin eRF3 discrepancies                strain Petergoff Breeding Stocks (XII race S. cerevi- <br /> precise localization region eRF1 interacts             siae) independent origin [31] compared eRF3 [19-22]. Domain 2 responsible pepti-             strains used laboratories [32]. <br /> dyl transferase hydrolytic activity includes GGQ <br /> motif highly conserved evolution                Comparison mutant SUP45 DNA sequences [23]. Mutations GGQ (<span id='am-32' about='obo:IMR_0100118' typeof='owl:Thing obo:IMR_0000967 obo:IMR_0000947 obo:IMR_0000965 obo:IMR_0001695 obo:IMR_0000001 obo:IMR_0100116'><span id='am-33' property="rdfs:label" content="Glycine" datatype="xsd:string"></span><span id='am-34' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-35' property="oboInOwl:hasExactSynonym" content="Glycine" datatype="xsd:string"></span><span id='am-36' property="oboInOwl:hasAlternativeId" content="IMR:0200057" datatype="xsd:string"></span><span id='am-37' property="oboInOwl:id" content="IMR:0100118" datatype="xsd:string"></span><span id='am-38' property="oboInOwl:hasExactSynonym" content="Gly" datatype="xsd:string"></span><span id='am-39' property="rdfs:label" content="Gly" datatype="xsd:string"></span><span id='am-40' property="oboInOwl:hasDbXref" content="KEGG:C00037" datatype="xsd:string"></span><span id='am-41' property="rdfs:label" content="Aminoacetic acid" datatype="xsd:string"></span><span id='am-42' property="rdfs:label" content="glycine" datatype="xsd:string"></span><span id='am-43' property="oboInOwl:hasExactSynonym" content="Aminoacetic acid" datatype="xsd:string"></span>Gly</span> residues) dominant-neg-               parent strain revealed cases ative vitro [23] lethal vivo S. cerevisiae cells [15].   single-base changed coding sequence. Surprisingly, function domain 1 remains unknown                  16 mutations 5 represented nonsense mutations, proposed domain 2, form               resulting mutations sense codon ochre functionally active &quot;core&quot; domain [24]. role N-              (TAA)  mutations) (TAG) nonsense codon  terminal domain eRF1 stop codon recognition                 mutation) (Figure 1). 9 missense muta- proposed [15] supported mutational                        tions described  Strains bearing <br /> approach [25] crosslinking experiments [26].                      sup45-101, sup45-102, sup45-104, sup45-105, sup45-107 <br />                                                                       contain, respectively, following base substitu- eukaryotes eRF1 interacts eRF3 vivo [27,28].               tions: G796T, T159A, T848A, G1153T T950G, interaction mediated C-terminus eRF1                lead nonsense mutations, characterized. <br /> [20,21]. deletion 19 C-terminal amino acids <br /> abolishes interaction eRF3, causes enhance-               Nonsense mutations SUP45 gene lead ment nonsense suppression, does destroy                readthrough mutated stop codon <br /> bility. contrast, eRF1 32 C-terminal amino acid             mutations defined omnipotent suppres- <br /> deletion unable support viability [20].             sors testing histidine, lysine, <span id='am-12' about='obo:IMR_0200350' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-13' property="oboInOwl:hasDbXref" content="KEGG:C00147" datatype="xsd:string"></span><span id='am-14' property="rdfs:label" content="Adenine" datatype="xsd:string"></span><span id='am-15' property="oboInOwl:id" content="IMR:0200350" datatype="xsd:string"></span><span id='am-16' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>adenine</span> tryp- shown nonsense mutations (UAA) SUP45                 tophan auxotrophy; his7-1 (UAA), lys9-A21 (UAA,) ade1- <br /> gene lead lethality absence SUQ5 suppressor              14 (UGA) trp1-289 (UAG) mutation present [29].  viable nonsense mutant iso-                 parent strain (Figure 2A). <br /> lated prfB gene S. typhimurium encoding RF2 <br /> release factor. proposed mutation               determine level nonsense suppression dif- <br /> reduces cellular RF2 leading inefficient             ferent SUP45 mutants vector based assay termination translation autosuppression [30].                  quantification nonsense codon readthroughin vivo                                                                       employed [33]. &#206;&#178;-galactosidase activities measurements present work isolated spontaneous                 mutants consistent results obtained nonsense mutations SUP45 gene confer viabil-              auxotrophy (Figure 2A): parent strain does possess <br /> ity different genetic backgrounds. mutations                 suppressor activity. omnipotent mutants tested, <br /> result decreased level length eRF1, thermosen-           nonsense suppression levels stop codons high <br /> sitivity lethality meiotic segregation hetero-               8- 28% UAA; 10- 25% zygous diploids.                                                      UAG, 22- 42% UGA) (Figure 2B). <br />  <br /> Results                                                               C-terminal region eRF1 essential cell  <br /> Isolation nonsense mutations SUP45 gene                     bility [10,11], length eRF1 present selection histidine (his7-1 (UAA)) &#226;&#8364;&#8220; lysine (lys9-          strains bearing sup45 nonsense mutations  A21 (UAA)) prototrophy, sixteen SUP45 mutants                     referred sup45-n, n equals nonsense), <br /> eighty SUP35 mutants 400  Lys+ rever-                  probably readthrough stop codon. affinity- <br />  <br />  <br />                                                                                                                           Page 2 13 <br />                                                                                                     (page number citation purposes) <br />  BMC Molecular Biology 2003, 4:2                                                http://www.biomedcentral.com/1471-2199/4/2 <br />  <br />  <br />  <br />  <br />                                                                suppression <br />                                                                Figure <br />                                                                Nonsense  2 mutations SUP45 gene lead omnipotent <br />                                                                Nonsense mutations SUP45 gene lead                                                                omnipotent suppression.  Plate assays showing                                                                growth yeast strains bearing nonsense mutations                                                                SUP45 gene (101-1B-D1606, 102-1B-D1606, 104-1B-D1606, <br /> Figure <br /> present <br /> Schematic1work <br />             representation sup45-n mutations isolated    105-1B-D1606, 107-1B-D1606) synthetic medium <br /> Schematic representation sup45-n mutations iso-             histidine (SC , lysine (SC-Lys), adenine (SC-Ade) <br /> lated present work. Position mutations indi-      tryptophan (SC-Trp) 25&#194;&#176;C compared parent <br /> cated SUP45 gene. numbers SUP45        strain 1B-D1606. types nonsense mutations parent <br /> gene correspond amino acid positions codons           strain denoted media indications. SUP45 mutant changed premature stop codons. Numbers          alleles indicated. serial dilutions yeast suspension <br /> right arrows correspond size truncated eRF1       density used. independent clones protein.                                                       tested, representative results shown. B. Determination <br />                                                                level nonsense suppression sup45-n mutants. <br />                                                                UAA, UAG UGA suppression levels quantified                                                                measuring &#206;&#178;-galactosidase levels strains 1B-D1606 <br /> purified anti-eRF1 antibody used Western blot <br />                                                                (wild type) control mutants transformed plas- <br /> analysis examine eRF1 levels SUP45 mutants.           mids pUKC817, pUKC818 pUKC819 bearing specific <br /> shown Figure 2C, considerable         stop codon (TAA, TAG TGA, respectively) frame length eRF1 sup45-n strains. Comparison         precedes lacZ gene. efficiency nonsense codon <br /> wild-type strain revealed significant decrease        readthrough (%) quantified ratio &#206;&#178;-galactosidase eRF1 protein. Ribosome fractions isolated            activity cells harboring lacZ stop codon cells sup45-104, sup45-105, sup45-107 contained trun-         stop codon frame lacZ gene cated protein molecular mass consistent          pUKC815 plasmids. strains Fig. 2A used. <br /> predicted (31.5, 43.0 35.2 kDa, respectively)          Results means separate experiments. C. <br /> (Figure 2C).                                                   Western blot showing synthesis length eRF1 (49 <br />                                                                kDa) truncated eRF1 proteins predicted molecular <br />                                                                mass 43.0 kDa, 35.2 kDa 31.5 kDa mutants 105, 107 <br /> Western blot analysis did reveal presence trun- <br />                                                                104, respectively. (*) Indicates non-specific band. cated protein ribosome fractions, lysates      search yeast proteome N-terminal peptide <br /> prepared sup45-101 strain (Figure 2C data         sequence used antibody production, revealed <br /> shown). inability detect truncated protein         presence protein (methionyl-tRNA synthetase, predicted molecular mass 29.6 kDa           GenBank accession number CAA24627) containing explained proteolytic sensitivity possibly   sequence expected molecular weight near 85 absence ribosome-binding site. small trun-      kDa. Cultures strains   grown cated protein (5.9 kDa) sup45-102 strain       mid-log phase medium selective plasmid ribosome <br /> detected. Relative level eRF1 wild-type strain    fractions prepared. sample <br /> 1B-D1606 (set 1), length eRF1         loaded lane. Immunoblot analysis performed <br /> 101-D1606, 102-D1606, 104-D1606, 105-D1606                 using polyclonal antibodies directed N-terminal <br />                                                                eRF1. <br /> 107-D1606 strains 0.32, 0.08, 0.13, 0.14 0.17, <br /> respectively. highest level eRF1 sup45-101 strain <br />  <br />  <br />                                                                                                                      Page 3 13 <br />                                                                                                (page number citation purposes) <br />  BMC Molecular Biology 2003, 4:2                                              http://www.biomedcentral.com/1471-2199/4/2 <br />  <br />  <br />  <br /> corresponds lowest level suppression meas-        pressor mutation parent strain plasmid, shuffle <br /> ured &#206;&#178;-galactosidase assay (Figure 2B). results       analysis performed derivative S288C [35] <br /> suggest small eRF1 required       entire genomic sequence does contain muta- <br /> cell viability.                                                tions tRNA genes [36]. haploid strain 1A-Y23282 <br />                                                                bearing SUP45 disruption [URA3 SUP45] plasmid effect reducing eRF1 cell viability evaluated    pRS316/SUP45 transformed [LEU2 sup45-n]  sup45-n mutations  missense muta-        plasmids resulting transformants plated tions, data shown) lead temperature-sensitive           5-FOA medium. transformants able grow lethality (Figure 3). Previously, analogous phenotype      presence 5-FOA (Figure 4D). <br /> caused opal supK584 mutation RF2 gene S. <br /> typhimurium explained reduced level            comparison data presented Figures 4A 4D <br /> mature RF2 protein higher temperature [30]. deter-       shows efficiency plasmid shuffle varies sig- case yeast strains carry-   nificantly mutations sup45-105 <br /> ing sup45-n alleles, ribosomes isolated wild-        highest sup45-101. compare efficiency <br /> type strain 1B-D1606 104-1B-D1606 strain          plasmid shuffle quantitatively maintenance plas- hours incubation 37&#194;&#176;C. Western blot         mid wild-type SUP45 tested. haploid yeast <br /> analysis did reveal significant difference      strain 1A-D1628 carrying SUP45 gene centromeric length eRF1 protein non-permissive       plasmid pRS315 transformed pRS316 plasmids <br /> temperature compared permissive tempera-           bearing different sup45-n mutations. Cotransformants <br /> ture mutant wild-type strains (data     plated 200 cells Petri dish YPD medium, shown).                                                    grown 25&#194;&#176;C days replica plated SC- <br />                                                                Ura SC-Leu media. 200 500 colonies tested sup45-n mutations lead lethality different genetic    3 independent transformants. cotransformants <br /> backgrounds?                                                   able lose [SUP45 LEU2] [sup45-n URA3] viability strains bearing nonsense mutations     plasmid different efficiency. plasmid pRS316 <br /> essential SUP45 gene explained ways.      bearing mutant sup45-n alleles lost 15&#226;&#8364;&#8220;20% possible parent strain itself contains weak tRNA   tested colonies (data shown). time suppressor.  level readthrough          small number colonies lost pRS315 plasmid wild- <br /> strain, measured quantitative termination codon           type SUP45. (Table 1, column). data  <br /> readthrough assay, negligible (Figure 2B).                  sistent result plasmid shuffle 5-FOA (Fig. <br />                                                                4A 4D): frequency wild-type plas- examine possibility plasmid shuffle analy-     mid loss (0.3%) obtained sup45-105 high- <br /> sis performed. haploid yeast strain 1A-D1628       est (6.3%) sup45-101. <br /> transformed pRS315 plasmids bearing different <br /> sup45-n mutations. strain lethal SUP45 disrup-     Ura+ Leu- colonies selected tested adenine <br /> tion complemented SUP45 gene URA3             tryptophan auxotrophy. cases sup45-n muta- <br /> centromeric plasmid, pRS316. Transformants           tions led suppression ade1-14 trp1-289 (Figure <br /> subjected plasmid shuffle analysis [34] verify           4B). Cells bearing pRS316/sup45-n plasmid trans- strains containing sup45-n alleles lose      formed pRS315-SUP45 plasmid experiment plasmid carrying wild-type gene. Leu+ Ura+ trans-      repeated (Table 1, second column). results formants plated 5-FOA medium select         growth presence mutant alleles SUP45 <br /> [URA3 SUP45] plasmid. Control cells transformed           ability lose plasmid wild-type allele [LEU2 SUP45] plasmid grew 5-FOA. Cells transformed          SUP45 increased. determine increase pRS315/sup45-n plasmids grew 5-FOA                explained reversions sup45-n alleles medium different efficiencies (Figure 4A).       wild-type allele shuffle experiments yeast, Ura- Leu+ colonies selected tested adenine        corresponding plasmids prepared yeast trans- tryptophan auxotrophy. cases sup45-n muta-          formants sequenced. tested cases presence tions lead suppression ade1-14 trp1-289 (Figure      sup45-n mutation confirmed (data shown). <br /> 4B).  Western blot analysis showed SUP45::HIS3 [sup45-n] strains length eRF1        nonsense mutations SUP45 gene lead synthesized lesser extent compared SUP45::HIS3       lethality meiosis? <br /> [SUP45] strain (Figure 4C).                                    Previously shown sup45 nonsense <br />                                                                mutants, selected presence SUQ5, viable confirm viability sup45-n mutations         absence SUQ5 tRNA suppressor [29]. explained presence weak tRNA sup-       work mutants viable distinct yeast <br />  <br />  <br />                                                                                                                   Page 4 13 <br />                                                                                             (page number citation purposes) <br />  BMC Molecular Biology 2003, 4:2                                                http://www.biomedcentral.com/1471-2199/4/2 <br />  <br />  <br />  <br />  <br /> Figure <br /> tivity 3 mutations SUP45 gene lead thermosensi- <br /> Nonsense                                                            different <br />                                                                 Nonsense <br />                                                                 Figure <br />                                                                      4 mutations <br />                                                                               genetic backgrounds <br />                                                                                       SUP45 gene confer viability Nonsense mutations SUP45 gene lead ther-              Nonsense mutations SUP45 gene confer mosensitivity. Thermosensitivity strains bearing sup45-n     viability different genetic backgrounds.  <br /> mutations. strains (2A) tested       Strain 1A-D1628 bearing SUP45 disruption trans- <br /> rich medium (YPD) 37&#194;&#176;C.                                      formed pRS316/SUP45 pRS315/sup45-n plasmids.                                                                 cotransformants bearing pRS316/SUP45 vector pRS315 <br />                                                                 used negative control. transformants <br />                                                                 assayed growth plating 5-FOA medium strains contain SUQ5. main         select URA3 plasmid pRS316/SUP45 carrying                                                                 wild-type copy SUP45. serial dilutions yeast suspen- <br /> difference data previously published <br />                                                                 sions density used. independent trans- <br /> data [29] explained different approaches           formants combination tested. Representative <br /> selection mutants used. addition, work, plas-     results shown. B. Plate assays showing growth mid shuffle analysis used test viability sup45-   transformants 1A-D1628 bearing pRS316/SUP45 n mutants analysis meiotic products used         pRS316/sup45-n plasmids synthetic medium characterize viability sup45-0 (0 ochre)   adenine (SC-Ade) tryptophan (SC-Trp) 25&#194;&#176;C. mutants [29].                                                   strains tested way Fig. 2A. C. West- <br />                                                                 ern blot showing expression length eRF1 (49 kDa) compare results ones Stansfield et al. [29]    truncated eRF1 proteins strains (B). D. transformed diploid strain D1628  parent strain        Complementation SUP45 gene disruption strain <br />                                                                 13A-Y23282 sup45-n mutations. transformants 1A-D1628 strain used plasmid shuffle experiment) het- <br />                                                                 vector pRS315 used negative control. erozygous SUP45 disruption plasmids carrying           plasmids   used. <br /> sup45-n alleles performed tetrad analysis. Table 2 <br /> shows  Ura+ segregants obtained case sup45-105 allele   marker SUP45 gene disruption Ura+ &#226;&#8364;&#8220; plasmid            using diploid strain Y23282, derivative presence). result explained loss       S288C (data shown). corresponding plasmid stability plasmids tested diploids practically (Table 2).     Microscopic examination lethal spores sup45-n alleles appearance  Ura+       control strain showed unable carry segregants registered,       mitotic divisions stayed cell stage. case plasmids wild-type SUP45.         result explained loss SUP45 bearing plas- presence sup45-n alleles Ura+ spore clones        mids. contrast, case diploids bearing mutant confirmed suppression ade1-14 trp1-289            sup45-n alleles lethal spores form microcolonies 4 <br /> alleles (data shown). results obtained        20 cells (Table 3), abnormally <br />  <br />  <br />                                                                                                                      Page 5 13 <br />                                                                                                (page number citation purposes) <br />  BMC Molecular Biology 2003, 4:2                                                                  http://www.biomedcentral.com/1471-2199/4/2 <br />  <br />  <br />  <br /> Table 1: efficiency maintenance pRS315/SUP45 plasmid SUP45::HIS3 [sup45-n] background <br />  <br />              Transformants 1A-D1628 bearing plasmids                              % Ura+ Leu- colonies rounds selection: <br />  <br />         pRS315 [LEU2]                   pRS316 [URA3]                             Ib                                   II c <br />  <br />                SUP45                                SUP45                               9.5 &#194;&#177; 1.1                            11.0 &#194;&#177; 0.7 <br />                SUP45                              sup45-101                             6.3 &#194;&#177; 0.8                            10.9 &#194;&#177; 1.1 <br />                SUP45                              sup45-102                             2.2 &#194;&#177; 0.7                            4.3 &#194;&#177; 0.9 <br />                SUP45                              sup45-104                             2.5 &#194;&#177; 0.9                            12.1 &#194;&#177; 2.2 <br />                SUP45                              sup45-105                             0.3 &#194;&#177; 0.2                            15.6 &#194;&#177; 1.7 <br />                SUP45                              sup45-107                             2.0 &#194;&#177; 0.3                            5.0 &#194;&#177; 0.6 <br />  <br />  Strain 1A-D1628 bearing disruption SUP45 gene (SUP45::HIS3) SUP45 gene pRS315 plasmid transformed pRS316/ <br />  sup45-n plasmids. b frequency pRS315/SUP45 loss cotransformants determined  . c Transformants bearing sup45-n plasmids <br />  selected SC- Ura medium, transformed pRS315/SUP45 plasmid frequency pRS315/SUP45 loss cotransformants  determined (II). 3 independent transformants tested plasmid combinations. average data standard errors (&#194;&#177; <br />  SE) presented. <br /> shaped buds abnormally elongated. Apparently,                           length eRF1 encoded SUP45 gene SUP45::HIS3 [sup45-n] spores germinate cells                       readthrough product encoded sup45-n allele. fail divide cell cycles.                                        known interaction eRF1 eRF3 mediated <br />                                                                                C-terminus eRF1 [20,21].  absence determine presence SUQ5 mutation                             readthrough, truncated eRF1 proteins encoded increase viability sup45-n segregants, dip-                   sup45-n alleles interact eRF3. Accordingly, yeast <br /> loid strain heterozygous SUQ5 sup45-n                         eRF3 fused GAL4DB vector pGBT9 eRF1/Sup45 <br /> alleles sporulated tetrads analyzed cell                      fused GAL4AD vector pGADGH introduced viability suppression (Table 4). expected, SUQ5                         strain HF7C separately tested activa- <br /> mutation significantly increased frequency                          tion HIS3 reporter gene. control experiment  <br /> Ura+ segregants sup45-n mutations sup45-                        transformants harboring plasmids vec- <br /> 107. data consistent known properties                       tor (pGBT9 pGADGH) did grow SUQ5 tRNA suppress UAA, UGA codon [33].                          absence histidine. transformants harboring <br />                                                                                yeast (eRF3/Sup35and eRF1/Sup45) length pro- <br /> Nonsense mutations SUP45 recognized stop                             teins used positive control. Figure 5A shows codons presence wild-type SUP45 allele                               transformants bearing length eRF1 eRF3 readthrough sup45-n mutations explained                        proteins grew selective medium 3-amino- ways decreased level eRF1 weak                      1,2,4-triazole (3 , transformants carrying <br /> termination context surrounding sup45-n mutations.                          truncated variants eRF1 did  <br /> assess possibilities determined sup45-n alleles reassigned presence wild-                   Western blot analysis revealed presence fusion pro- <br /> type SUP45 allele. purpose hybrid                      tein wild-type eRF1 protein transform- used [37]. approach allows distinguish                     ants, sup45-102 (Figure 5B). readthrough <br />  <br /> Table 2: Nonsense mutations SUP45 lead decreased ascospore viability <br />  <br />   D1628 transformed        Plasmid      Total number tetrads   Tetrads indicated number viable spores     % Ura+ segregants          plasmids:             stability % <br />  <br />                                                                            4           3              2           1 <br />  <br />  pRS316/SUP45                      71                  49                  7           19            22           1                     27 <br />  pRS316/sup45-101                  74                  52                  6            6            38           2                     15 <br />  pRS316/sup45-102                  71                  30                  1            1            26           2                      5 <br />  pRS316/sup45-104                  74                  48                  0            2            42           4                      2 <br />  pRS316/sup45-105                  72                  35                  0            0            32           3                      0 <br />  pRS316/sup45-107                  69                  31                  3            5            21           2                     14 <br />  <br />  Ura+ segregants characteristic sup45-n allele presence   marker SUP45 gene disruption Ura+-  pRS316 plasmid presence). data correspond sum experiments cell number nonviable colonies calculated  (Table 3). <br />  <br />  <br />                                                                                                                                         Page 6 13 <br />                                                                                                                 (page number citation purposes) <br />  BMC Molecular Biology 2003, 4:2                                                          http://www.biomedcentral.com/1471-2199/4/2 <br />  <br />  <br />  <br /> Table 3: Nonsense mutations SUP45 lead block cell divisions spore formation <br />  <br />   D1628 transformed    Total number non-viable   Percentage non-viable spores forming microcolony following numbers cells: <br />          plasmids:                   spores <br />  <br />                                                                    5&#226;&#8364;&#8220;20                         3&#226;&#8364;&#8220;4                              1 <br />  <br />  pRS316/SUP45                           22                          0                            0                              100 <br />  pRS316/sup45-101                       68                          3                            1                               96 <br />  pRS316/sup45-102                       52                          15                           25                              60 <br />  pRS316/sup45-104                       64                          8                            28                              64 <br />  pRS316/sup45-105                       39                          13                           18                              69 <br />  pRS316/sup45-107                       25                          24                           8                               68 <br />  <br />  <br />  <br />  <br /> proteins observed plasmids bearing                    existence mutated nonsense-suppressed tRNA gene sup45-n mutations sup45-101, small                     genetic background parent strain employed readthrough fusion protein detected.                   study unlikely, codon-specificity presence normal wild-type eRF1                  suppressors: work ochre (UAA) opal <br /> readthrough sup45-n alleles completely repressed.                   (UGA) sup45-n mutations isolated.                                                                           parent strain strains used testing viability Discussion                                                                sup45-n mutations, possess suppressor activity. study shown yeast containing non-                     mutations tRNA encoding genes sense mutations SUP45 gene selected                  strain S288C [40], derivative used viable strains. product gene, translation termi-              plasmid shuffle experiments. <br /> nation factor eRF1, essential small deletions C-terminus  30 amino acids) lethal                     Viable opal nonsense mutation (supK584) essential <br /> [20,21]. Consistent  shown                gene prfB encoding bacterial release factor RF2 length eRF1 protein present mutants bearing                     described S. typhimurium [30]. shown sup45-n alleles, smaller amounts.                             mutation reduces cellular RF2.                                                                           reduction RF2 level leads inefficient termination processes known overcome                   translation autosuppression. Nonsense muta- <br /> effect nonsense codons, suppression                  tions isolated essential SUP35 gene <br /> mutated natural cellular RNA [reviewed [38]].                   encoding translation termination factor eRF3, readthrough frame stop-codon pro-                     (sup35-2 (UAG) sup35-21 (UAA)) [41,42]  <br /> grammed weak termination context RNA-sec-                       ble.  different translation termination factors, ondary structure elements  [1] recent review].                    RF2, eRF1 eRF3, common property &#226;&#8364;&#8220;  <br />                                                                           bility nonsense mutants encoding genes. Non- commonly used E. coli laboratory strains                   sense mutations SUP45 gene (sup45-0) SUQ5- wild-type populations contain UAG suppressor                      ochre suppressing background previously iso- <br /> tRNAs [39]. S. cerevisiae data unknown.                  lated;  support viability  <br /> Table 4: Nonsense mutations SUP45 support ascospore viability presence SUQ5 <br />  <br />    Strain D1638      Total number                         Number tetrads viable spores                              % Ura+ <br />  transformed        tetrads                                                                                                segregants <br />      plasmids: <br />  <br />                                                 4                    3                    2                    1 <br />  <br />  pRS316/SUP45              35                   8                   12                   14                    1                      32 <br />  pRS316/sup45-101          36                   11                  11                   13                    1                      33 <br />  pRS316/sup45-102          31                   9                   10                   11                    1                      35 <br />  pRS316/sup45-104          20                   1                   7                    11                    1                      17 <br />  pRS316/sup45-105          36                   6                   10                   18                    2                      30 <br />  pRS316/sup45-107          36                   2                   9                    24                    1                      18 <br />  <br />  <br />  <br />  <br />                                                                                                                                  Page 7 13 <br />                                                                                                            (page number citation purposes) <br />  BMC Molecular Biology 2003, 4:2                                                   http://www.biomedcentral.com/1471-2199/4/2 <br />  <br />  <br />  <br />                                                                    occurrence natural sites termination efficiency                                                                    tetranucleotide stop codon [44,45]. UAA stop codon <br />                                                                    termination efficiency influenced fourth posi- <br />                                                                    tion order G &gt; &gt; U &#226;&#8240;&#165; C  efficient                                                                    efficient termination) frequent +4  <br />                                                                    text S. cerevisiae  C frequent [45].                                                                    accordance data relative level eRF1  <br />                                                                    length protein correlates strength transla- <br />                                                                    tion termination signal (Table 5). UAAA mutations <br />                                                                    isolated screen. UGA stop codon trans- <br />                                                                    lation efficiency influenced fourth position                                                                    order G&gt;U C, UAG order different <br />                                                                     U&gt;C&gt;G) [45].  sup45-107 (UGAA) mutation, <br />                                                                    sup45-n mutations, situated weak <br />                                                                    termination context.  premature stop codons                                                                    SUP45 gene suppressed relatively high effi- <br />                                                                    ciency depending surrounding sequence. <br />  <br />                                                                    Interestingly, sup45-0 mutations, led appear- <br />                                                                    ance frame UAA stop codon [29], situated                                                                    strongest +4 context purine presented Expression 5of eRF1 <br /> Figure        sup45-n mutations <br />                     protein                                        does notinlead presence wild-type <br />                                               readthrough          fourth position. discrepancy Expression sup45-n mutations presence                 data Stansfield et al. explained wild-type eRF1 protein does lead                  different context influence viable sup45-n <br /> readthrough.  hybrid interactions. Strain HF7C           mutation completely identical sup45-18 [29] transformed pGADGH plasmids carrying different             isolated (Borchsenius, Zhouravleva, unpub- <br /> sup45-n mutations pGBT9/SUP35 plasmid. interac-            lished).  readthrough premature stop codons <br /> tions tested extent resistance 3          SUP45 gene explained weak ter- <br /> serial dilutions yeast suspensions density     mination context presence wild-type <br /> used. independent transformants combination          eRF1 protein readthrough fusion Gal4- tested. Representative results shown. B. Western <br />                                                                    Sup45-n mRNAs. Interestingly, possibility isolating <br /> blot showing expression length eRF1+Gal4 truncated eRF1+Gal4 proteins predicted molecular              viable nonsense mutations SUP45 gene mass transformants  .                          existence wild-type tRNAs yeast cytoplasm                                                                    predicted [29]. Natural nonsense suppression                                                                    widespread mechanism translation regulation <br /> absence SUQ5 mutation leading lethality               [reviewed [38]]. <span id='am-6' about='oboInOwl:date' typeof='owl:Thing'>date</span>, ability different yeast <br /> crosses wild-type strain [20].                                tRNA translate stops codons shown <br />                                                                    [46-48]. Experiments progress identify precise known relative efficiency termination       mechanism leading readthrough sup45-n mutations. <br /> depends local sequence context surrounding termination codon [reviewed [1,2,43]]. numerous              sup45-n mutations lead lethality dif- <br /> experiments E. coli shown             ferent genetic backgrounds, viability increased important determinant termination efficiency             growth absence wild-type allele. mainte- <br /> nucleotide immediately following stop codon  +4            nance plasmid containing wild-type copy base). suggests translation termination signal       SUP45 gene changed: frequency loss consists nucleotides [39,44]. Statistical analysis      low compared plasmid bearing sup45-n mutation, <br /> sequences surrounding stop codons natural termina-               frequency significantly increased tion sites shown significant bias bases          reshuffle SUP45 bearing plasmid sup45-n mutants. stop codon, marked             crosses sup45-n strains wild-type <br /> nucleotide immediately following stop codon                    strain viability segregants bearing sup45-n alleles <br /> [reviewed [39,43]]. analysis identified contexts           higher meiotic progeny diploid cells heter- favor termination vivo different organisms,             ozygous SUP45 disruption. Possibly, additional muta- E. coli S. cerevisiae.          tions selected stage selection,  <br /> context different bacteria yeast, quite       alternatively, decreased level eRF1 influence <br /> good correlation frequency +4 nucleotide            expression components translation termi- <br />  <br />  <br />                                                                                                                        Page 8 13 <br />                                                                                                  (page number citation purposes) <br />  BMC Molecular Biology 2003, 4:2                                                      http://www.biomedcentral.com/1471-2199/4/2 <br />  <br />  <br />  <br /> Table 5: efficiency UAA-readthrough sup45-n mutations depends base following stop codon <br />  <br />  SUP45 allele   Termination tetranucleotide   Level eRF1 (% wild type)   Natural occurrence highly expressed genes (%) [45] <br />  <br />   sup45-102               UAAG                               8                                           35.9 <br />   sup45-104               UAAU                              13                                           16.7 <br />   sup45-105               UAAU                              14                                           16.7 <br />   sup45-101               UAAC                              32                                           1.3 <br />  <br />  <br />  <br />  <br /> nation complex. studies necessary identify             amino acid positions corresponding premature precise mechanism phenomenon.                             stop codons.  sup45-n mutations situ- <br />                                                                       ated highly conserved regions eRF1 (data known high levels nonsense suppression               shown). <br /> yeast lethal [49]. sup45-n mutations lead decreased spore viability. Spores bearing sup45-n muta-               Previously shown truncated eRF1 proteins <br /> tions characterized limited growth germina-              411, 360 359 amino acids able bind tion leading formation micro-colonies 4 20            ribosome [29]. experiments truncated eRF1 <br /> cells. arrest cell division sup45-n bearing spores          proteins 384, 316 282 amino acids, 265 explained presence residual                  amino acids, bind ribosome. result suggests eRF1 protein derived heterozygous diploid.                eRF1 ribosome-binding site localized shown disruption SUP45 gene leads                amino acids 265 282. Consistent data, blockage cell cycle START G1, manifested          previously proposed human eRF1 inability spores produce microcolonies [50].             ribosome-binding site includes amino acids 246 270 <br /> Interestingly, presence mutated suppressor tRNA                [24]. led increase spore lethality [51] arrest cell division approximately 50-cell stage [52].            eRF3-binding site S. cerevisiae eRF1 located combination sup45-n alleles SUQ5 mutation                     C-terminal region, particular deletion restores viability sup45-n spores sup45-0           eRF1 19 C-terminal amino acids abolish interac- <br /> mutations [29].                                                       tion eRF3 [20,21]. hybrid analysis used                                                                       work confirms loss extreme C-terminus sup45-n mutations  missense mutations)                eRF1 abolishes interaction eRF3. <br /> led thermosensitivity. data concerning effi- <br /> ciency translation termination different temperatures           studies described raise question mech- controversial: S. typhimurium higher 42&#194;&#176;C           anisms leading viability nonsense mutations 37&#194;&#176;C supK584 wild-type strains [30].              essential genes. date mutations isolated S. cerevisiae efficiency termination did           essential genes S. cerevisiae [41,42,54,55] change wild-type strain, lower 33&#194;&#176;C            existence different mechanisms pro- 30&#194;&#176;C sup45 mutant [33]. did sig-              posed. Viability pol3 nonsense mutations nificant difference length eRF1 pro-            explained presence [PSI+] factor encoded tein non-permissive temperature compared               SUP35 gene parent strain, leads permissive temperature mutant sup45-104               readthrough stop codons mutated POL3 gene <br /> strain wild-type strain. thermosensitivity            [55]. Analysis snm1 nonsense mutations revealed sup45-n mutants explained                 mutations suppressed amplification reduction eRF1 protein produced               plasmid carrying snm1 alleles. Plasmid amplification <br /> mutant high temperature proposed RF2 protein                leads increase SNM1 mRNA level,  supK584 strain [30].                                               believed led partial readthrough resulting                                                                       appearance length Snm1 protein. Interestingly, sup45-n mutations lead high level nonsense                snm1 mutations result translation infidelity sug- <br /> codon suppression  42% UGA stop codon                  gesting translation suppression specific measured &#206;&#178;-galactosidase assay)                     SNM1 gene [54]. viability sup35-2 sup35-21 <br /> decreased level eRF1. result consistent pre-          mutations explained reduction eRF3 level vious findings [29,53].  additional causes                causes inefficient termination translation leads excluded length eRF1 protein produced              autosuppression [41,42].  precise mecha- sup45-n mutants contains missense substitutions             nism leading readthrough mutations,  <br />  <br />                                                                                                                            Page 9 13 <br />                                                                                                      (page number citation purposes) <br />  BMC Molecular Biology 2003, 4:2                                                http://www.biomedcentral.com/1471-2199/4/2 <br />  <br />  <br />  <br /> sup45-n mutations, remains unclear. Future studies         hybrid interactions assessed ability include identification components partici-      transactivate HIS3 reporter gene  confer growth pate process.                                           absence histidine presence different  <br />                                                                 centrations 3 . <br /> Conclusions data presented work nonsense muta-        Bacterial strains used work JM109 (recA1 <br /> tions (sup45-n) SUP45 gene isolated      supE44 endA1 hsdR17 gyrA96 relA1 thi &#206;&#8221; (lac-proAB) F&apos; mutations support viability different genetic      [traD36 proAB+lacIqlacZ&#206;&#8221;M15]) [61] XL1-Blue (recA1, <br /> grounds. mutations lead decreased level       endA1, gyrA96, thi-1, hsdR17, supE44, relA1 [F&apos;, proAB, lacIq, length eRF1 protein ability suppress    &#206;&#8221;(lacZ)M15, Tn10(tet)]) [62]. nonsense mutations. appear low <br /> level eRF1  10% relative wild type) sufficient   quantitative characterization nonsense suppression support viability. sup45-n mutations situated     sup45 mutants &#206;&#178;-galactosidase reporter [33] weak +4 termination context relative level eRF1      used. Mutants transformed pUKC815 plasmid length protein correlates strength    containing PGK1-lacZ fusion (control) pUKC817, <br /> nucleotide translation termination signal. sup45-       818, 819 plasmids carrying TAA, TAG, TGA (termination <br /> n mutations lead decreased spore viability thermo-       codons), respectively, cloned frame lacZ. &#206;&#178;-galac- <br /> sensitivity. data confirm site interaction      tosidase activity determined described [63]. eRF3 localized C-terminus eRF1.           case nonsense suppression active &#206;&#178;-galac- <br /> results suggest ribosome-binding site yeast         tosidase synthesized. Efficiencies suppression eRF1 localized amino acids 265 282.              calculated ratio &#206;&#178;-galactosidase activity cells har- <br />                                                                 boring lacZ premature termination codon Methods                                                         cells normal allele lacZ. Values liquid &#206;&#178;-galac- <br /> Strains, media reagents                                     tosidase assay represent mean assays Saccharomyces cerevisiae strains used study     independent transformants. <br /> listed additional file 1. strains [psi-]. Strains <br /> BSC483/4c D1628 described earlier                 DNA/RNA methods <br /> [56,57]. Yeast cultures grown standard rich (YPD)       Plasmid DNA isolated described [62]. Yeast synthetic (SC) media [58] 25&#194;&#176;C. Usually, omnipo-          genomic DNA prepared using lyticase (Sigma) tent SUP45 mutations selected reversions          genomic DNA purification kit (Promega). <br /> nonsense mutations different types  example, UAA UGA)  [59] review], decreases proba-       SUP45 ORF amplified PCR genomic <br /> bility obtaining mutations tRNA genes. work       DNA yeast strains using oligonucleotides correspond- used reversions nonsense mutations             ing 5&apos; ORF (82 &#226;&#8364;&#8220; CATTTCGGCTTGTCTCC type (UAA). yeast strain 1B-D1606 containing           99 &#226;&#8364;&#8220; TTTGTGATTCCATGAAGAGGATAACAGA CT) nonsense mutations types constructed.          oligonucleotide, complementary 3&apos; end selection suppressor mutants, simultaneous spon-         ORF (83 &#226;&#8364;&#8220; TCTGGCATCTAGTGATTAAATTC). PCR reac- <br /> taneous reversions histidine lysine prototrophy          tions performed using Taq Pfu polymerase employed.  Lys+ revertants crossed           (Promega) recommended manufacturer. <br /> strains bearing sup35 sup45 mutations identify            Sequences PCR primers used double strand <br /> SUP45 mutants. Standard methods yeast genetics          sequencing  82, 83  , 45 &#226;&#8364;&#8220; CGACTGCAC- <br /> used [58]. Transformants grown media selec-         CTAAATCCAATG, 87 &#226;&#8364;&#8220; CCTCATTATCCTCGGCATC, 92 &#226;&#8364;&#8220; <br /> tive plasmid maintenance (SC-Trp, SC-Leu, SC-Ura).          GTTCGATGTCAAAAGTGAC, 93 &#226;&#8364;&#8220; GACGAAATTTC- <br /> Suppression nonsense mutations estimated              CCAGGACAC, 94 &#226;&#8364;&#8220; CAAAAACTTCGGTGCTAC, 100 &#226;&#8364;&#8220; <br /> growth 25&#194;&#176;C synthetic media lacking corre-            GACATCGAACCTTACAAACCTATC, 101 &#226;&#8364;&#8220; ctgctatcacttc- <br /> sponding amino acids. determine frequency             cacccaac, 104 &#226;&#8364;&#8220; GAAAGGTCGCCGAAGTTGCTG, 105 &#226;&#8364;&#8220; <br /> plasmid loss transformants plated 200 cells         CAGCAACTTCGGCGACCTTTC. independent <br /> Petri dish YPD medium, grown 25&#194;&#176;C             PCR-products sequenced subcloned pGEM-T <br /> days replica plated SC-Ura SC-Leu media.              vector (Promega). presence mutated allele 200 500 colonies 3 independent trans-             pGEM-T plasmid verified sequencing. <br /> formants, tested. plasmid shuffle, selective <br /> medium containing 1 mg/ml 5-fluoroorotic acid (5-FOA,           Plasmids <br /> Sigma) used. Yeast transformations performed           Plasmid pRS316/ySUP45 constructed subcloning described previously [60]. 3 plates contained differ-     XbaI-HindIII fragment pYex-SUP45  gift V. <br /> ent concentrations 3-amino-1,2,4-triazole (Sigma).       Kushnirov) sites pRS316 [64]. Plasmid <br />  <br />  <br />                                                                                                                     Page 10 13 <br />                                                                                                (page number citation purposes) <br />  BMC Molecular Biology 2003, 4:2                                                  http://www.biomedcentral.com/1471-2199/4/2 <br />  <br />  <br />  <br /> pRS315/SUP45 described earlier [57]. Plasmids            Additional material <br /> pRS316/sup45-101, pRS316/sup45-102, pRS316/sup45- <br /> 104, pRS316/sup45-107 obtained substitution BglII-EcoRI fragment pRS316/SUP45 BglII- <br />                                                                   Additional File 1 <br />                                                                   Table 6. Yeast strains used study <br /> EcoRI fragments pGEM-T/sup45-101, pGEM-T/                    Click file <br /> sup45-102, pGEM-T/sup45-104 pGEM-T/sup45-107,                 [http://www.biomedcentral.com/content/supplementary/1471- <br /> respectively. Plasmid pRS316/sup45-105 obtained            2199-4-2-S1.ppt] <br /> substituting BglII-BamHI fragment pRS316/SUP45 BglII-BamHI fragment pGEM-T/sup45-105. Plas- <br /> mids pRS315/sup45-101, pRS315/sup45-102, pRS315/ <br /> sup45-104, pRS315/sup45-105, pRS315/sup45-107            Acknowledgments obtained substituting BglII-BamHI fragment        grateful M. Tuite V. Kushnirov yeast strains pRS315/SUP45 BglII-BamHI fragments pRS316/          plasmids; C. Le Goff technical assistance M.D.Ter-Avane- <br /> sup45-101,      pRS316/sup45-102,    pRS316/sup45-104,       syan helpful discussion. thank H.B.Osborne reading                                                              manuscript. work supported common grant CNRS (PICS <br /> pRS316/sup45-105 pRS316/sup45-107, respectively. <br />                                                              1113), S.M., S.Ch., S V., G  RFBR (00-04-22001NCNI_a), S.M., <br />                                                              S.Ch., S V. CRDF ST-012-0, S V., G  CRDF RB1-2336- <br /> Plasmids pGBT9/SUP35 pGADGH/SUP45                   ST-02. S.M INTAS(YSF-00-19). <br /> described previously [41]. Plasmids pGADGH/sup45-101, <br /> pGADGH/sup45-102,          pGADGH/sup45-104              References <br /> pGADGH/sup45-107 obtained substituting BglII-        1.      Bertram G, Innes S, Minella O, Richardson J, Stansfield  Endless <br /> EcoRI fragment pGADGH/SUP45 BglII-EcoRI frag-                 possibilities: translation termination stop codon recog- <br />                                                                      nition. Microbiology 2001, 147:255-269. <br /> ment pGEM-T/sup45-101, pGEM-T/sup45-102,                2.      Kisselev LL, Buckingham RH: Translational termination comes <br /> pGEM-T/sup45-104 pGEM-T/sup45-107, respectively.                 age. Trends Biochem Sci 2000, 25:561-566. <br />                                                              3.      Nakamura Y, Ito K, Ehrenberg M: Mimicry grasps reality trans- <br /> Plasmid pGADGH/sup45-105 obtained substitut-                  lation termination. Cell 2000, 101:349-352. <br /> ing BglII-BamHI fragment pGADGH/SUP45 BglII-          4.      Poole E, Tate W: Release factors role decoding <br /> BamHI fragment pGEM-T/sup45-105.                                proteins: specificity fidelity termination protein <br />                                                                      synthesis. Biochim Biophys Acta 2000, 1493:1-11. <br />                                                              5.      Frolova L, Le GX, Rasmussen HH, Cheperegin S, Drugeon G, Kress <br /> Protein procedures                                                   M: highly conserved eukaryotic protein family possessing <br /> Yeast cultures grown YPD medium                      properties polypeptide chain release factor. Nature 1994, <br />                                                                      372:701-703. <br /> medium selective plasmid markers. Ribosomal frac-        6.      Craigen WJ, Lee CC, Caskey CT: Recent advances peptide <br /> tions prepared described [65].            chain termination. Mol Microbiol 1990, 4:861-865. <br />                                                              7.      Caskey CT, Forrester WC, Tate W, Ward CD: Cloning &#206;&#188;g proteins separated 12 % SDS-polyacry-              Escherichia coli release factor 2 gene. J Bacteriol 1984, <br /> lamide gel according Laemmli [66], transferred             158:365-368. nitrocellulose membrane (Immobilon-P). Western blot        8.      Scolnick E, Tompkins R, Caskey T, Nirenberg M: Release factors <br />                                                                      differing specificity terminator codons. Proc Natl Acad Sci <br /> analysis performed 1/100 diluted polyclonal                 U S 1968, 61:768-774. <br /> rabbit antibodies obtained mixture      9.      Weiss RB, Murphy JP, Gallant JA: Genetic screen cloned <br />                                                                      release factor genes. J Bacteriol 1984, 158:362-364. <br /> peptides N-terminal (CLTDEYGTASNIKSRV)              10.     Breining P, Piepersberg W: Yeast omnipotent supressor SUP1 C-terminal (VDESEDEYYDEDEGS) regions S.                   (SUP45): nucleotide sequence wild type mutant <br /> cerevisiae eRF1 purified N-terminal             gene. Nucleic Acids Res 1986, 14:5187-5197. <br />                                                              11.     Himmelfarb HJ, Maicas E, Friesen JD: Isolation SUP45 <br /> peptide eRF1. Bound antibodies detected using                omnipotent suppressor gene Saccharomyces cerevisiae Amersham ECF (Amersham Pharmacia Bio-                     characterization gene product. Mol Cell Biol 1985, <br /> tech) Storm 840 PhosphorImager (Molecular                    5:816-822. <br />                                                              12.     Nakamura Y, Ito K, Matsumura K, Kawazu Y, Ebihara K: Regulation <br /> Dynamics, USA). Signal intensities quantified using             translation termination: conserved structural motifs ImageQuaNT 5.2 software (Molecular Dynamics, USA).                   bacterial eukaryotic polypeptide release factors. Biochem <br />                                                                      Cell Biol 1995, 73:1113-1122. <br />                                                              13.     Ito K, Ebihara K, Uno M, Nakamura Y: Conserved motifs Authors&apos; contributions                                               prokaryotic eukaryotic polypeptide release factors: <br /> SM experiments described                tRNA-protein mimicry hypothesis. Proc Natl Acad Sci U S 1996, <br />                                                                      93:5443-5448. <br /> paper, GZ SS performed initial cloning sequenc-      14.     Ito K, Uno M, Nakamura Y: tripeptide &apos;anticodon&apos; deciphers <br /> ing sup45 mutations. SI, MP GA supervised             stop codons messenger RNA. Nature 2000, 403:680-684. <br /> work participated coordination. authors read   15.     Song H, Mugnier P, Das AK, Webb HM, Evans DR, Tuite MF:                                                                      crystal structure human eukaryotic release factor eRF1 &#226;&#8364;&#8220; approved final manuscript.                                   mechanism stop codon recognition peptidyl-tRNA <br />                                                                      hydrolysis. Cell 2000, 100:311-321. <br />                                                              16.     Klaholz B, Pape T, Zavialov AV, Myasnikov AG, Orlova EV, Vester- <br />                                                                      gaard B: Structure Escherichia coli ribosomal termina- <br />                                                                      tion complex release factor 2. Nature 2003, 421:90-94. <br />                                                              17.     Vestergaard B, Van LB, Andersen GR, Nyborg J, Buckingham RH, <br />                                                                      Kjeldgaard M: Bacterial polypeptide release factor RF2  <br />  <br />                                                                                                                        Page 11 13 <br />                                                                                                   (page number citation purposes) <br />  BMC Molecular Biology 2003, 4:2                                                                 http://www.biomedcentral.com/1471-2199/4/2 <br />  <br />  <br />  <br />       structurally distinct eukaryotic eRF1. Mol Cell 2001,              38.   Beier H, Grimm M: Misreading termination codons       8:1375-1382.                                                                  eukaryotes natural nonsense suppressor tRNAs. Nucleic <br /> 18.   Scarlett DJ, McCaughan KK, Wilson DN, Tate WP: Mapping func-                  Acids Res 2001, 29:4767-4782. <br />       tionally important motifs SPF GGQ decoding                   39.   Tate WP, Poole ES, Mannering SA: Hidden infidelities       release factor RF2 Escherichia coli ribosome                        translational stop signal. Prog Nucleic Acid Res Mol Biol 1996, <br />       hydroxyl radical footprinting. Implications macromo-                      52:293-335. <br />       lecular mimicry structural changes RF2. J Biol Chem           40.   Percudani R, Pavesi  Ottonello S: Transfer RNA gene redun- <br />       press.                                                                        dancy translational selection Saccharomyces cerevisiae. <br /> 19.   Ebihara K, Nakamura Y: C-terminal interaction translational                J Mol Biol 1997, 268:322-330. <br />       release factors eRF1 eRF3 fission yeast: G-domain                41.   Cosson B, Couturier  Chabelskaya S, Kiktev D, Inge-Vechtomov S, <br />       uncoupled binding role conserved amino acids.                      Philippe M: Poly -binding protein acts translation termi- <br />       RNA 1999, 5:739-750.                                                          nation eukaryotic release factor 3 interaction does <br /> 20.   Eurwilaichitr L, Graves FM, Stansfield  Tuite MF: C-terminus            influence [PSI+] propagation.             Mol Cell Biol 2002, <br />       eRF1 defines functionally important domain transla-                  22:3301-3315. <br />       tion termination Saccharomyces cerevisiae. Mol Microbiol             42.   Zhou P, Derkatch  Uptain SM, Patino MM, Lindquist S, Liebman <br />       1999, 32:485-496.                                                             SW: yeast non-Mendelian factor [ETA+] variant 21.   Ito K, Ebihara K, Nakamura Y: stretch C-terminal acidic                [PSI+], prion-like form release factor eRF3. EMBO J 1999, <br />       amino acids translational release factor eRF1 primary                 18:1182-1191. <br />       binding site eRF3 fission yeast. RNA 1998, 4:958-972.            43.   Tate WP, Mannering SA:   translational <br /> 22.   Merkulova TI, Frolova LY, Lazar M, Camonis J, Kisselev LL: C-termi-           stop signal length. Mol Microbiol 1996, 21:213-219. <br />       nal domains human translation termination factors eRF1               44.   Poole ES, Brown CM, Tate WP: identity base follow- <br />       eRF3 mediate vivo interaction. FEBS Lett 1999,                   ing stop codon determines efficiency vivo trans- <br />       443:41-47.                                                                    lational termination Escherichia coli.          EMBO J 1995, <br /> 23.   Frolova LY, Tsivkovskii RY, Sivolobova GF, Oparina NY, Serpinsky              14:151-158. <br />       OI, Blinov VM: Mutations highly conserved GGQ motif              45.   Bonetti B, Fu L, Moon J, Bedwell DM: efficiency translation <br />       class 1 polypeptide release factors abolish ability human               termination determined synergistic interplay <br />       eRF1 trigger peptidyl-tRNA hydrolysis.                 RNA 1999,           upstream downstream sequences Saccharo- <br />       5:1014-1020.                                                                  myces cerevisiae. J Mol Biol 1995, 251:334-345. <br /> 24.   Frolova LY, Merkulova TI, Kisselev LL: Translation termination       46.   Weiss WA, Edelman  Culbertson MR, Friedberg EC: Physiological <br />       eukaryotes: polypeptide release factor eRF1 composed                    levels normal tRNA(CAGGln) effect partial suppres- <br />       functionally structurally distinct domains. RNA 2000,                     sion amber mutations yeast Saccharomyces cerevi- <br />       6:381-390.                                                                    siae. Proc Natl Acad Sci U S 1987, 84:8031-8034. <br /> 25.   Bertram G, Bell HA, Ritchie DW, Fullerton G, Stansfield  Termi-       47.   Pure GA, Robinson GW, Naumovski L, Friedberg EC: Partial sup- <br />       nating eukaryote translation: domain 1 release factor                      pression ochre mutation Saccharomyces cerevisiae       eRF1 functions stop codon recognition. RNA 2000,                           multicopy plasmids containing normal yeast tRNAGln <br />       6:1236-1247.                                                                  gene. J Mol Biol 1985, 183:31-42. <br /> 26.   Chavatte L, Frolova L, Kisselev L, Favre  polypeptide chain       48.   Tuite MF, McLaughlin CS: Endogenous read UGA <br />       release factor eRF1 specifically contacts s(4)UGA stop                    termination codon Saccharomyces cerevisiae cell-free sys- <br />       codon located site eukaryotic ribosomes. Eur J Bio-               tem: evidence involvement mitochondrial       chem 2001, 268:2896-2904.                                                     nuclear tRNA. Mol Cell Biol 1982, 2:490-497. <br /> 27.   Zhouravleva G, Frolova L, Le Goff X, Le Guellec R, Inge-Vechtomov       49.   Liebman SW, Sherman F: Inhibition growth amber sup- <br />       S, Kisselev L, Philippe M: Termination translation eukaryo-             pressors yeast. Genetics 1976, 82:233-249. <br />       tes governed interacting polypeptide chain release            50.   Borkhsenius  Inge-Vechtomov SG:  role SUP35       factors, eRF1 eRF3. EMBO J 1995, 14:4065-4072.                            SUP45 genes controlling Saccharomycetes cell cycle]. Dokl <br /> 28.   Stansfield  Jones KM, Kushnirov VV, Dagkesamanskaya AR, Poznya-             Akad Nauk 1997, 353:553-556. <br />       kovski AI, Paushkin SV: products SUP45 (eRF1)            51.   Louis EJ, Haber JE: Nonrecombinant meiosis nondisjunction       SUP35 genes interact mediate translation termination                    Saccharomyces cerevisiae induced tRNA ochre suppres- <br />       Saccharomyces cerevisiae. EMBO J 1995, 14:4365-4373.                          sors. Genetics 1989, 123:81-95. <br /> 29.   Stansfield  Eurwilaichitr L, Akhmaloka , Tuite MF: Depletion   52.   Edelman  Culbertson MR: Exceptional codon recognition       levels release factor eRF1 causes reduction                   glutamine tRNAs Saccharomyces cerevisiae. EMBO J <br />       efficiency translation termination yeast. Mol Microbiol                 1991, 10:1481-1491. <br />       1996, 20:1135-1143.                                                     53.   Valouev IA, Kushnirov VV, Ter-Avanesyan MD: Yeast polypeptide <br /> 30.   Kawakami K, Nakamura Y: Autogenous suppression opal                     chain release factors eRF1 eRF3 involved cytoskel- <br />       mutation gene encoding peptide chain release factor                    eton organization cell cycle regulation. Cell Motil Cytoskel- <br />       2. Proc Natl Acad Sci U S 1990, 87:8432-8436.                               eton 2002, 52:161-173. <br /> 31.   Inge-Vechtomov SG: New genetic lines yeast Saccharomyces             54.   Cai T, Reilly TR, Cerio M, Schmitt  Mutagenesis SNM1, <br />       cerevisiae. Vestnik LGU  Russian) 1963, 21:117-125.                        encodes protein component yeast RNase <br /> 32.   Mortimer RK, Johnston JR: Genealogy principal strains               MRP, reveals role ribonucleoprotein endoribonu- <br />       yeast genetic stock center. Genetics 1986, 113:35-43.                         clease plasmid segregation. Mol Cell Biol 1999, 19:7857-7869. <br /> 33.   Stansfield  Akhmaloka , Tuite MF: mutant allele SUP45        55.   Kokoska RJ, Stefanovic L, DeMai J, Petes TD: Increased rates       (SAL4) gene Saccharomyces cerevisiae shows temperature-                    genomic deletions generated mutations yeast gene <br />       dependent allosuppressor omnipotent suppressor phe-                       encoding DNA polymerase delta decreases cel- <br />       notypes. Curr Genet 1995, 27:417-426.                                         lular levels DNA polymerase delta. Mol Cell Biol 2000, <br /> 34.   Boeke JD, LaCroute F, Fink GR: positive selection mutants               20:7490-7504. <br />       lacking orotidine-5&apos;-phosphate decarboxylase activity                56.   Eaglestone SS, Cox BS, Tuite MF: Translation termination effi- <br />       yeast: 5-fluoro-<span id='am-7' about='obo:IMR_0200265' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-8' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-9' property="oboInOwl:id" content="IMR:0200265" datatype="xsd:string"></span><span id='am-10' property="rdfs:label" content="Orotic acid" datatype="xsd:string"></span><span id='am-11' property="oboInOwl:hasDbXref" content="KEGG:C00295" datatype="xsd:string"></span>orotic acid</span> resistance. Mol Gen Genet 1984,                   ciency regulated Saccharomyces cerevisiae envi- <br />       197:345-346.                                                                  ronmental stress prion-mediated mechanism. <br /> 35.   Brachmann CB, Davies  Cost GJ, Caputo E, Li J, Hieter P: Designer           EMBO J 1999, 18:1974-1981. <br />       deletion strains derived Saccharomyces cerevisiae                  57.   Le Goff C, Zemlyanko O, Moskalenko S, Berkova N, Inge-Vechtomov <br />       S288C: useful set strains plasmids PCR-mediated                  S, Philippe M: Mouse GSPT2, GSPT1, substitute <br />       gene disruption applications.                  Yeast 1998,          yeast eRF3 vivo. Genes Cells 2002, 7:1043-1057. <br />       14:115-132.                                                             58.   Sherman F, Fink GR, Hicks JB, Cold Spring HL: Laboratory course <br /> 36.   Hani J, Feldmann H: tRNA genes retroelements yeast                 manual methods yeast genetics. Cold Spring Harbor, Cold <br />       genome. Nucleic Acids Res 1998, 26:689-696.                                   Spring Harbor Press 1986. <br /> 37.   Fields S, Song O: novel genetic detect protein-pro- <br />       tein interactions. Nature 1989, 340:245-246. <br />  <br />  <br />  <br />                                                                                                                                       Page 12 13 <br />                                                                                                                  (page number citation purposes) <br />  BMC Molecular Biology 2003, 4:2                                                               http://www.biomedcentral.com/1471-2199/4/2 <br />  <br />  <br />  <br /> 59.   Inge-Vechtomov SG, Mironova LN, Ter-Avanesyan MD: [Ambiguity <br />       translation: eukaryotic version?].            Genetika 1994, <br />       30:1022-1035. <br /> 60.   Gietz RD, Schiestl RH, Willems AR, Woods RA: Studies       transformation intact yeast cells LiAc/SS-DNA/ <br />       PEG procedure. Yeast 1995, 11:355-360. <br /> 61.   Yanisch-Perron C, Vieira J, Messing J: Improved M13 phage clon- <br />       ing vectors host strains: nucleotide sequences       M13mp18 pUC19 vectors. Gene 1985, 33:103-119. <br /> 62.   Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: labora- <br />       tory manual. Cold Spring Harbor, Cold Spring Harbor Press 1989. <br /> 63.   Burke D, Dawson D, Stearns T, Cold Spring HL: Methods yeast <br />       genetics. Cold Spring Harbor, Cold Spring Harbor Laboratory Press <br />       2000. <br /> 64.   Sikorski RS, Hieter P: shuttle vectors yeast host <br />       strains designed efficient manipulation DNA Saccha- <br />       romyces cerevisiae. Genetics 1989, 122:19-27. <br /> 65.   Didichenko SA, Ter-Avanesyan MD, Smirnov VN: Ribosome- <br />       bound EF-1 alpha-like protein yeast Saccharomyces cerevi- <br />       siae. Eur J Biochem 1991, 198:705-711. <br /> 66.   Laemmli UK: Cleavage structural proteins       assembly head bacteriophage T4. Nature 1970, <br />       227:680-685. <br />  <br />  <br />  <br />  <br />                                                                                    Publish Bio Med Central                                                                                   scientist read work free charge <br />                                                                               &quot;BioMed Central significant development                                                                               disseminating results biomedical researc h lifetime.&quot; <br />                                                                                    Sir Paul Nurse, Cancer Research UK <br />  <br />                                                                                  research papers  <br />                                                                                    available free charge entire biomedical community <br />                                                                             <br /> </body></html>